Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity
Authors:
- Pablo FernándezPFPablo Fernández
- Alejandra RiveraARAlejandra Rivera
- Edilia AndrewsEAEdilia Andrews
- Angel OñateAOAngel Oñate
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu–Zn superoxide dismutase protein against Brucella abortusVaccine, 2011
- Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challengeVaccine, 2011
- Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infectionJournal of Experimental Medicine, 2009
- Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4 + and CD8 + T Cells as Well as Systemic and Oral Protection against Brucella abortus InfectionInfection and Immunity, 2009
- Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000Microbial Cell Factories, 2008
- A Combined DNA Vaccine Encoding BCSP31, SOD, and L7/L12 Confers High Protection Against Brucella abortus 2308 by Inducing Specific CTL ResponsesDNA and Cell Biology, 2007
- Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity againstStreptococcus pneumoniaeInfectionInfection and Immunity, 2001
- Bovine Rotavirus Nonstructural Protein 4 Produced by Lactococcus lactis Is Antigenic and ImmunogenicApplied and Environmental Microbiology, 2001
- Intranasal Interleukin‐12 is a Powerful Adjuvant for Protective Mucosal ImmunityThe Journal of Infectious Diseases, 1999
- Brucellosis: an OverviewEmerging Infectious Diseases, 1997